1. Home
  2. VKTX vs FNB Comparison

VKTX vs FNB Comparison

Compare VKTX & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • FNB
  • Stock Information
  • Founded
  • VKTX 2012
  • FNB 1864
  • Country
  • VKTX United States
  • FNB United States
  • Employees
  • VKTX N/A
  • FNB N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • FNB Major Banks
  • Sector
  • VKTX Health Care
  • FNB Finance
  • Exchange
  • VKTX Nasdaq
  • FNB Nasdaq
  • Market Cap
  • VKTX 4.6B
  • FNB 5.1B
  • IPO Year
  • VKTX 2015
  • FNB N/A
  • Fundamental
  • Price
  • VKTX $42.25
  • FNB $14.50
  • Analyst Decision
  • VKTX Strong Buy
  • FNB Buy
  • Analyst Count
  • VKTX 12
  • FNB 6
  • Target Price
  • VKTX $106.75
  • FNB $17.67
  • AVG Volume (30 Days)
  • VKTX 3.7M
  • FNB 2.3M
  • Earning Date
  • VKTX 02-05-2025
  • FNB 01-16-2025
  • Dividend Yield
  • VKTX N/A
  • FNB 3.29%
  • EPS Growth
  • VKTX N/A
  • FNB N/A
  • EPS
  • VKTX N/A
  • FNB 1.09
  • Revenue
  • VKTX N/A
  • FNB $1,492,800,000.00
  • Revenue This Year
  • VKTX N/A
  • FNB N/A
  • Revenue Next Year
  • VKTX N/A
  • FNB $4.66
  • P/E Ratio
  • VKTX N/A
  • FNB $13.40
  • Revenue Growth
  • VKTX N/A
  • FNB N/A
  • 52 Week Low
  • VKTX $17.23
  • FNB $12.49
  • 52 Week High
  • VKTX $99.41
  • FNB $17.70
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 33.93
  • FNB 27.32
  • Support Level
  • VKTX $37.80
  • FNB $16.04
  • Resistance Level
  • VKTX $48.55
  • FNB $16.67
  • Average True Range (ATR)
  • VKTX 2.54
  • FNB 0.41
  • MACD
  • VKTX -0.45
  • FNB -0.30
  • Stochastic Oscillator
  • VKTX 30.11
  • FNB 6.90

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

Share on Social Networks: